China Biologic Products, Inc. (CBPO) is a publicly traded company in the Unknown sector. Across all available filings, 31 corporate insiders have executed 195 transactions totaling $3.4B, demonstrating a bearish sentiment with -$3.2B in net insider flow. The most recent transaction on May 9, 2017 involved a transaction of 1,142 shares valued at $11.2K.
No significant insider buying has been recorded for CBPO in the recent period.
No significant insider selling has been recorded for CBPO in the recent period.
Based on recent SEC filings, insider sentiment for CBPO is bearish with an Insider Alignment Score of 3/100 and a net flow of -$3.2B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at China Biologic Products, Inc. (CBPO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 31 insiders are actively trading CBPO stock, having executed 195 transactions in the past 90 days. The most active insider is Min Fang (Executive), who has made 2 transactions totaling $763.5M.
Get notified when executives and directors at CBPO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| May 9, 2017 | Cbpo Liu Zhijing | Executive | Option Exercise | 1,142 | $9.85 | $11.2K | |
| May 9, 2017 | Cbpo Liu Zhijing | Executive | Sale | 1,142 | $115.40 | $131.8K | |
| May 8, 2017 | Cbpo Liu Zhijing | Executive | Sale | 6,358 | $116.68 | $741.9K | Large |
| May 8, 2017 | Cbpo Liu Zhijing | Executive | Option Exercise | 6,358 | $9.85 | $62.6K | |
| Mar 2, 2017 | Shao Sean | Executive | Sale | 16,000 | $100.80 | $1.6M | Large |
| Mar 1, 2017 | Gao David | Executive | Sale | 54,049 | $100.57 | $5.4M | Large |
| Mar 1, 2017 | Shao Sean | Executive | Sale | 4,000 | $100.70 | $402.8K | |
| Feb 28, 2017 | Gao David | Executive | Sale | 62,604 | $100.69 | $6.3M | Large |
| Dec 9, 2016 | Yeung Albert | Executive | Option Exercise | 5,000 | $9.85 | $49.3K | |
| Dec 9, 2016 | Yeung Albert | Executive | Option Exercise | 20,000 | $10.57 | $211.4K | |
| Aug 15, 2016 | Liu Wenfang | Executive | Sale | 2,900 | $124.32 | $360.5K | |
| Aug 15, 2016 | Cbpo Liu Zhijing | Executive | Sale | 1,968 | $124.32 | $244.7K | |
| Aug 15, 2016 | Cbpo Yang Gang | Executive | Sale | 8,400 | $124.32 | $1.0M | Large |
| Aug 15, 2016 | Yin Ming | Executive | Sale | 20,334 | $124.32 | $2.5M | Large |
| Aug 15, 2016 | Yang Ming | Executive | Sale | 21,092 | $124.32 | $2.6M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 85 | $3.3B | 96.8% |
Purchase(P) | 31 | $103.5M | 3.1% |
Exercise(M) | 22 | $3.2M | 0.1% |
Award(A) | 56 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at China Biologic Products, Inc. has increased, with 31 insiders executing 195 transactions across all time. Total sales of $3.3B significantly outpace purchases of $103.5M, resulting in a net outflow of $3.2B. This selling activity appears largely discretionary, which may warrant closer attention from investors.